
Transactions: Sweden
Filter


Secondary placing of 19.5 million shares in Fabege (SE) — SEK 663 million

Secondary placing of 7 million shares in Intrum Justitia (SE) — EUR 41 million

Rights issue in Active Biotech (SE) — SEK 255 million

Option program in Biovitrum (SE)

Acquisition of Attendo AB (SE) by Bridgepoint (UK) — SEK 2.2 billion

Public offer for Biacore International (SE) by GE Healthcare (US) — SEK 3.2 billion

Block trade of shares in Swedish Orphan Biovitrum (SE) — SEK 231 million

Initial public offering of Castellum (SE) — SEK 1.8 billion

Secondary placing of 10.85 million shares in NCC (SE) — SEK 1.2 billion

Divestment of Infratek ASA (NO) to Triton (SE) by Hafslund ASA (NO) and Fortum Nordic AB (SE) — NOK 0.9 billion
